NanoViricides
NNVC
#10088
Rank
โ‚น2.26 B
Marketcap
โ‚น104.87
Share price
2.46%
Change (1 day)
0.56%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น55.01. In 2024 the company made an earnings per share (EPS) of -โ‚น63.12 an increase over its 2023 EPS that were of -โ‚น66.73.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น52.14-17.4%
2024-โ‚น63.12-5.41%
2023-โ‚น66.735.71%
2022-โ‚น63.12-13.58%
2021-โ‚น73.04-66.11%
2020-โ‚น215.521.7%
2019-โ‚น211.91-10.98%
2018-โ‚น238.06-22.35%
2017-โ‚น306.59-10.53%
2016-โ‚น342.66375%
2015-โ‚น72.14-85.19%
2014-โ‚น486.9442.11%
2013-โ‚น342.6626.67%
2012-โ‚น270.52-6.25%
2011-โ‚น288.5614.28%
2010-โ‚น252.49100%
2009-โ‚น126.24-0%
2008-โ‚น126.24-33.33%
2007-โ‚น189.37-0%
2006-โ‚น189.374445.07%
2005-โ‚น4.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.51-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น191.17-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น587.93-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น267.82-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น684.76-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น324.26-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK